Natural genetic variations in bovine leukemia virus envelope gene: Possible effects of selection and escape

Virology

Volumn 366, Issue 1, 2007, Pages 150-165

  Zhao, Xiangrong ^a   Buehring, Gertrude C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bovine leukemia virus; Conformational model; Deletion; env; Phylogeny; Polymorphism; Selection

Indexed keywords

EPITOPE; GLYCOPROTEIN GP 51; GLYCOPROTEIN GP30; SIGNAL PEPTIDE; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BOVINE LEUKEMIA VIRUS; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DNA FLANKING REGION; GENE CLUSTER; GENE DELETION; GENE MUTATION; GENE SEQUENCE; GENETIC SELECTION; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; IMMUNOGENICITY; NONHUMAN; PHYLOGENY; PRIORITY JOURNAL; PROTEIN DOMAIN; VIRUS ISOLATION;

AMINO ACID SEQUENCE; BASE SEQUENCE; CONSENSUS SEQUENCE; CONSERVED SEQUENCE; GENOME, VIRAL; GEOGRAPHY; LEUKEMIA VIRUS, BOVINE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PHYLOGENY; PROTEIN CONFORMATION; SELECTION (GENETICS); SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, AMINO ACID; VARIATION (GENETICS); VIRAL ENVELOPE PROTEINS;

BOS; BOVINE LEUKEMIA VIRUS; DELTARETROVIRUS; RETROVIRIDAE; SIMIAN T-LYMPHOTROPIC VIRUS 3;

EID: 34548167105     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.03.058     Document Type: Article

References (59)

1. Asfaw Y., Tsuduku S., Konishi M., Murakami K., Tsuboi T., Wu D., and Sentsui H. Distribution and superinfection of bovine leukemia virus genotypes in Japan. Arch. Virol. 150 (2005) 493-505
2. Ban J., Czene S., Altaner C., Callebaut I., Krchnak V., Merza M., Burny A., Kettmann R., and Portetelle D. Mapping of sequential epitopes recognized by monoclonal antibodies on the bovine leukaemia virus external glycoproteins expressed in Escherichia coli by means of antipeptide antibodies. J. Gen. Virol. 73 (1992) 2457-2461
3. Blanchard S., Astier-Gin T., Tallet B., Moynet D., Londos-Gagliardi D., and Guillemain B. Amino acid changes at positions 173 and 187 in the human T-cell leukemia virus type 1 surface glycoprotein induce specific neutralizing antibodies. J. Virol. 73 (1999) 9369-9376
4. Bruck C., Mathot S., Portetelle D., Berte C., Franssen J.D., Herion P., and Burny A. Monoclonal antibodies define eight independent antigenic regions on the bovine leukemia virus (BLV) envelope glycoprotein gp51. Virology 122 (1982) 342-352
5. Bruck C., Rensonnet N., Portetelle D., Cleuter Y., Mammerickx M., Burny A., Mamoun R., Guillemain B., van der Maaten M., and Ghysdael J. Biologically active epitopes of bovine leukemia virus glycoprotein gp51: their dependence on protein glycosylation and genetic variability. Virology 136 (1984) 20-31
6. Buehring G.C., Philpott S.M., and Choi K.Y. Humans have antibodies reactive with bovine leukemia virus. AIDS Res. Hum. Retroviruses 19 (2003) 1105-1113
7. Callebaut I., Burny A., Krchnak V., Gras-Masse H., Wathelet B., and Portetelle D. Use of synthetic peptides to map sequential epitopes recognized by monoclonal antibodies on the bovine leukemia virus external glycoprotein. Virology 185 (1991) 48-55
8. Callebaut I., Voneche V., Mager A., Fumiere O., Krchnak V., Merza M., Zavada J., Mammerickx M., Burny A., and Portetelle D. Mapping of B-neutralizing and T-helper epitopes on the bovine leukemia virus external glycoprotein gp51. J. Virol. 67 (1993) 5321-5327
9. Camargos M.F., Stancek D., Rocha M.A., Lessa L.M., Reis J.K., and Leite R.C. Partial sequencing of env gene of bovine leukaemia virus from Brazilian samples and phylogenetic analysis. J. Vet. Med., B 49 (2002) 325-331
10. Camargos M.F., Pereda A., Stancek D., Rocha M.A., Reis J.K., Greiser-Wilke I., and Leite R.C. Molecular characterization of the env gene from Brazilian field isolates of bovine leukemia virus. Virus Genes 34 (2006) 343-350
11. Cantor G.H. A potential proline-rich motif upstream of the immunoreceptor tyrosine-based activation motif in bovine leukemia virus gp30, Epstein-Barr virus LMP2A, herpesvirus papio LMP2A, and African horsesickness virus VP7. Virology 220 (1996) 265-266
12. Chackerian B., Rudensey L.M., and Overbaugh J. Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies. J. Virol. 71 (1997) 7719-7727
13. Cheng-Mayer C., Brown A., Harouse J., Luciw P.A., and Mayer A.J. Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation. J. Virol. 73 (1999) 5294-5300
14. Daniel R.C., Gatei M.H., Good M.F., Boyle D.B., and Lavin M.F. Recombinant viral vaccines for enzootic bovine leucosis. Immunol. Cell. Biol. 71 (1993) 399-404
15. Dimitrov A.S., Rawat S.S., Jiang S., and Blumenthal R. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion. Biochemistry 42 (2003) 14150-14158
16. Dube S., Bachman S., Spicer T., Love J., Choi D., Esteban E., Ferrer J.F., and Poiesz B.J. Degenerate and specific PCR assays for the detection of bovine leukaemia virus and primate T cell leukaemia/lymphoma virus pol DNA and RNA: phylogenetic comparisons of amplified sequences from cattle and primates from around the world. J. Gen. Virol. 78 (1997) 1389-1398
17. Dube S., Dolcini G., Abbott L., Mehta S., Dube D., Gutierrez S., Ceriani C., Esteban E., Ferrer J., and Poiesz B. The complete genomic sequence of a BLV strain from a Holstein cow from Argentina. Virology 277 (2000) 379-386
18. Fass D., Davey R.A., Hamson C.A., Kim P.S., Cunningham J.M., and Berger J.M. Structure of a murine leukemia virus receptor-binding glycoprotein at 2.0 angstrom resolution. Science 277 (1997) 1662-1666
19. Fechner H., Blankenstein P., Looman A.C., Elwert J., Geue L., Albrecht C., Kurg A., Beier D., Marquardt O., and Ebner D. Provirus variants of the bovine leukemia virus and their relation to the serological status of naturally infected cattle. Virology 237 (1997) 261-269
20. Felmer R., Munoz G., Zuniga J., and Recabal M. Molecular analysis of a 444 bp fragment of the bovine leukaemia virus gp51 env gene reveals a high frequency of non-silent point mutations and suggests the presence of two subgroups of BLV in Chile. Vet. Microbiol. 108 (2005) 39-47
21. Gallaher W.R., Ball J.M., Garry R.F., Martin-Amedee A.M., and Montelaro R.C. A general model for the surface glycoproteins of HIV and other retroviruses. AIDS Res. Hum. Retroviruses 11 (1995) 191-202
22. Gatot J.S., Callebaut I., Mornon J.P., Portetelle D., Burny A., Kerkhofs P., Kettmann R., and Willems L. Conservative mutations in the immunosuppressive region of the bovine leukemia virus transmembrane protein affect fusion but not infectivity in vivo. J. Biol. Chem. 273 (1998) 12870-12880
23. Gatot J.S., Callebaut I., van Lint C., Demonte D., Kerkhofs P., Portetelle D., Burny A., Willems L., and Kettmann R. Bovine leukemia virus SU protein interacts with zinc, and mutations within two interacting regions differently affect viral fusion and infectivity in vivo. J. Virol. 76 (2002) 7956-7967
24. Goodenow M.M., and Hayward W.S. 5' long terminal repeats of myc-associated proviruses appear structurally intact but are functionally impaired in tumors induced by avian leukosis viruses. J. Virol. 61 (1987) 2489-2498
25. Graves D.C., and Ferrer J.F. In vitro transmission and propagation of the bovine leukemia virus in monolayer cell cultures. Cancer Res. 36 (1976) 4152-4159
26. Hadlock K.G., Goh C.J., Bradshaw P.A., Perkins S., Lo J., Kaplan J.E., Khabbaz R., and Foung S.K. Delineation of an immunodominant and human T-cell lymphotropic virus (HTLV)-specific epitope within the HTLV-I transmembrane glycoprotein. Blood 86 (1995) 1392-1399
27. Hall W.W., Liu C.R., Schneewind O., Takahashi H., Kaplan M.H., Roupe G., and Vahlne A. Deleted HTLV-I provirus in blood and cutaneous lesions of patients with mycosis fungoides. Science 253 (1991) 317-320
28. Inabe K., Nishizawa M., Tajima S., Ikuta K., and Aida Y. The YXXL sequences of a transmembrane protein of bovine leukemia virus are required for viral entry and incorporation of viral envelope protein into virions. J. Virol. 73 (1999) 1293-1301
29. Johnson W.E., Sanford H., Schwall L., Burton D.R., Parren P.W., Robinson J.E., and Desrosiers R.C. Assorted mutations in the envelope gene of simian immunodeficiency virus lead to loss of neutralization resistance against antibodies representing a broad spectrum of specificities. J. Virol. 77 (2003) 9993-10003
30. Johnston E.R., and Radke K. The SU and TM envelope protein subunits of bovine leukemia virus are linked by disulfide bonds, both in cells and in virions. J. Virol. 74 (2000) 2930-2935
31. Johnston E.R., Albritton L.M., and Radke K. Envelope proteins containing single amino acid substitutions support a structural model of the receptor-binding domain of bovine leukemia virus surface protein. J. Virol. 76 (2002) 10861-10872
32. Kobe B., Center R.J., Kemp B.E., and Poumbourios P. Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 4319-4324
33. Kojima K., Sawada T., Yasukawa M., Matsuo Y., Yakushijin Y., Narumi H., Azuma T., Takimoto H., and Hara M. Deleted HTLV provirus in peripheral blood cells of a patient with T-cell prolymphocytic leukaemia. Br. J. Haematol. 100 (1998) 567-570
34. Kumar S., Tamura K., and Nei M. MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform. 5 (2004) 150-163
35. Licursi M., Inoshima Y., Wu D., Yokoyama T., Gonzalez E.T., and Sentsui H. Genetic heterogeneity among bovine leukemia virus genotypes and its relation to humoral responses in hosts. Virus Res. 86 (2002) 101-110
36. Liu Y., McNevin J., Cao J., Zhao H., Genowati I., Wong K., McLaughlin S., McSweyn M.D., Diem K., Stevens C.E., Maenza J., He H., Nickle D.C., Shriner D., Holte S.E., Collier A.C., Corey L., McElrath M.J., and Mullins J.I. Selection on the human immunodeficiency virus type 1 proteome following primary infection. J. Virol. 80 (2006) 9519-9529
37. Mamoun R.Z., Morisson M., Rebeyrotte N., Busetta B., Couez D., Kettmann R., Hospital M., and Guillemain B. Sequence variability of bovine leukemia virus env gene and its relevance to the structure and antigenicity of the glycoproteins. J. Virol. 64 (1990) 4180-4188
38. Molteni E., Agresti A., Meneveri R., Marozzi A., Malcovati M., Bonizzi L., Poli G., and Ginelli E. Molecular characterization of a variant of proviral bovine leukaemia virus (BLV). Zentralbl. Veterinarmed. Beih. 43 (1996) 201-211
39. Novakovic S., Sawai E.T., and Radke K. Dileucine and YXXL motifs in the cytoplasmic tail of the bovine leukemia virus transmembrane envelope protein affect protein expression on the cell surface. J. Virol. 78 (2004) 8301-8311
40. Nunn M., Chan S., and Duesberg P.H. Complete env gene deletions of three replication-defective strains of Rous sarcoma virus and a model for the origin of their genetic structures. Virology 134 (1984) 466-471
41. Ogawa Y., Sagata N., Tsuzuku-Kawamura J., Koyama H., Onuma M., Izawa H., and Ikawa Y. Structure of a defective provirus of bovine leukemia virus. Microbiol. Immunol. 31 (1987) 1009-1015
42. Ohshima K., Kikuchi M., Yoneda S., Kobari S., Sumiyosi Y., Takeshita M., and Kimura N. Restriction of T cell receptor variable region in lymph nodes of adult T cell leukemia/lymphoma. Hematol. Oncol. 11 (1993) 147-154
43. Penciolelli J.F., Wendling F., Robert-Lezenes J., Barque J.P., Tambourin P., and Gisselbrecht S. Genetic analysis of myeloproliferative leukemia virus, a novel acute leukemogenic replication-defective retrovirus. J. Virol. 61 (1987) 579-583
44. Portetelle D., Dandoy C., Burny A., Zavada J., Siakkou H., Gras-Masse H., Drobecq H., and Tartar A. Synthetic peptides approach to identification of epitopes on bovine leukemia virus envelope glycoprotein gp51. Virology 169 (1989) 34-41
45. Portetelle D., Couez D., Bruck C., Kettmann R., Mammerickx M., van der Maaten M., Brasseur R., and Burny A. Antigenic variants of bovine leukemia virus (BLV) are defined by amino acid substitutions in the NH2 part of the envelope glycoprotein gp51. Virology 169 (1989) 27-33
46. Reeves R.H., and O'Brien S.J. Molecular genetic characterization of the RD-114 gene family of endogenous feline retroviral sequences. J. Virol. 52 (1984) 164-171
47. Reichert M., Winnicka A., Willems L., Kettmann R., and Cantor G.H. Role of the proline-rich motif of bovine leukemia virus transmembrane protein gp30 in viral load and pathogenicity in sheep. J. Virol. 75 (2001) 8082-8089
48. Rice N.R., Stephens R.M., Couez D., Deschamps J., Kettmann R., Burny A., and Gilden R.V. The nucleotide sequence of the env gene and post-env region of bovine leukemia virus. Virology 138 (1984) 82-93
49. Roy-Burman Y. A novel truncated env gene isolated from a feline leukemia virus-induced thymic lymphosarcoma. J. Virol. 74 (2000) 1451-1456
50. Sagata N., Yasunaga T., Tsuzuku-Kawamura J., Ohishi K., Ogawa Y., and Ikawa Y. Complete nucleotide sequence of the genome of bovine leukemia virus: its evolutionary relationship to other retroviruses. Proc. Natl. Acad. Sci. USA 82 (1985) 677-681
51. Sheets R.L., Pandey R., Jen W.C., and Roy-Burman P. Recombinant feline leukemia virus genes detected in naturally occurring feline lymphosarcomas. J. Virol. 67 (1993) 3118-3125
52. Tchenio T., and Heidmann T. Defective retroviruses can disperse in the human genome by intracellular transposition. J. Virol. 65 (1991) 2113-2118
53. Watanabe N., Yugawa T., Ikawa Y., and Amanuma H. Both the changes of six amino acids and the C-terminal truncation caused by a one-base insertion in the defective env gene of Friend spleen focus-forming virus significantly affect the pathogenic activity of the encoded leukemogenic membrane glycoprotein (gp55). J. Virol. 69 (1995) 7606-7611
54. Westaway D., Payne G., and Varmus H.E. Proviral deletions and oncogene base-substitutions in insertionally mutagenized c-myc alleles may contribute to the progression of avian bursal tumors. Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 843-847
55. Willems L., Gatot J.S., Mammerickx M., Portetelle D., Burny A., Kerkhofs P., and Kettmann R. The YXXL signalling motifs of the bovine leukemia virus transmembrane protein are required for in vivo infection and maintenance of high viral loads. J. Virol. 69 (1995) 4137-4141
56. Willems L., Burny A., Collete D., Dangoisse O., Dequiedt F., Gatot J.S., Kerkhofs P., Lefebvre L., Merezak C., Peremans T., Portetelle D., Twizere J.C., and Kettmann R. Genetic determinants of bovine leukemia virus pathogenesis. AIDS Res. Hum. Retroviruses 16 (2000) 1787-1795
57. Zaghawa A., Beier D., Abd El-Rahim I.H., Karim I., El-ballal S., Conraths F.J., and Marquardt O. An outbreak of enzootic bovine leukosis in upper Egypt: clinical, laboratory and molecular-epidemiological studies. J. Vet. Med., B 49 (2002) 123-129
58. Zhao X., Jimenez C., Sentsui H., and Buehring G.C. Sequence polymorphisms in the long terminal repeat of bovine leukemia virus: evidence for selection pressures in regulatory sequences. Virus Res. 124 (2007) 113-124
59. Zhao X., McGirr K.M., and Buehring G.C. Potential evolutionary influences on overlapping reading frames in the bovine leukemia virus pXBL region. Genomics 89 (2007) 502-511